glp-1 telehealth crackdown news Ozempic Knockoffs Survive Crackdown Thanks to Loophole

As interest in GLP-1 medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them. http://www.wyff4.com/article/weight-loss-scam-warning-fueled-by-glp-1 -hype-ai-deepfakes/69917014

27.86

★★★★☆4.8 (126)

FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s

27.94

★★★★★4.9 (98)

The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.'

22.45

★★★★★5.0 (157)

The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the

23.25

★★★★★4.7 (84)

FDA Targets Telehealth Compounded GLP-1 Marketing in New Warning Letters

25.75

★★★★★4.9 (203)

Despite FDA crackdown, unapproved GLP-1s still threaten the industry

28.34

★★★★★5.0 (176)

Watch GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs

20.11

★★★★★4.8 (132)